Invest now
Bafna Pharmaceuticals share price
High risk
You have to be logged in to add this to Watchlist.- ₹303.00(1.99%)September 11, 2026 15:15:00 PM IST
- NSE
- BSE
- Vol : 12.16 K (NSE + BSE)Last 20 day avg : 14.52 K
Bafna Pharmaceuticals is trading 1.99% upper at Rs 303.00 as compared to its last closing price. Bafna Pharmaceuticals has been trading in the price range of 303.00 & 297.50. Bafna Pharmaceuticals has given 100.01% in this year & 1.89% in the last 5 days. Bafna Pharmaceuticals has TTM P/E ratio 65.19 as compared to the sector P/E of 36.32.The company posted a net profit of 0.08 Crores in its last quarter.Listed peers of Bafna Pharmaceuticals include Sun Pharmaceutical Industries (-1.18%), Divi's Laboratories (-0.84%), Torrent Pharmaceuticals (0.95%).The Mutual Fund holding in Bafna Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Bafna Pharmaceuticals was at 9.34% in 30 Jun 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 15 Sep 2026, 08:07 AM IST
- BetaLow volatility0.62Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.39The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values7.42The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values93.12Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-60.05The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Bafna Pharmaceuticals Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,842.00 | -1.18 | 4,41,947.09 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,326.00 | -0.84 | 2,47,576.00 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,975.00 | 0.95 | 1,89,226.24 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,365.00 | -1.09 | 1,10,191.95 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,119.50 | 0.13 | 1,11,670.55 | 21.19 | 4.24 | 0.09 | 14.22 |
Bafna Pharmaceuticals Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
About the company Bafna Pharmaceuticals
- IndustryBiotechnology & Drugs
- ISININE878I01022
- BSE Code532989
- NSE CodeBAFNAPH
Bafna Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing of pharmaceutical formulations. The Company exports its products to the Europe, the United Kingdom, Australia, Sri Lanka, Africa, and Commonwealth countries.
Bafna Pharmaceuticals Share Price FAQs
Bafna Pharmaceuticals is trading at 303.00 as on Fri Sep 11 2026 09:45:00. This is 1.99% upper as compared to its previous closing price of 297.10.
The market capitalization of Bafna Pharmaceuticals is 716.79 Cr as on Fri Sep 11 2026 09:45:00.
The 52 wk high for Bafna Pharmaceuticals is 318.00 whereas the 52 wk low is 95.00
Bafna Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 65.19
- Sector P/E: 36.32
- Dividend Yield: 0.00%
- D/E ratio: -
Bafna Pharmaceuticals reported a net profit of 11.10 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Bafna Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.